Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 156, 76-85
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81570732, 81870568)
This publication has 46 references indexed in Scilit:
- Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic MiceHypertension, 2012
- Biochemistry and Cell Biology of Tau Protein in Neurofibrillary DegenerationCold Spring Harbor Perspectives in Medicine, 2012
- Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregationNature Chemical Biology, 2012
- Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetesActa Diabetologica, 2011
- Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal PhosphotransferasesThe Journal of Neuroscience, 2011
- Increased Expression of β-N-Acetylglucosaminidase in Erythrocytes From Individuals With Pre-diabetes and DiabetesDiabetes, 2010
- Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s diseaseJournal of Neurochemistry, 2009
- Differential Regulation of Dynein and Kinesin Motor Proteins by TauScience, 2008
- Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker CandesartanHypertension, 2007
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970